News and Presentations
NEWS
May 22, 2024
Company to Pursue Applications in Rare Diseases and Proprietary Medical Food Domains
Deal Unlocks Opportunities for Future Collaborations
October 4, 2023
Presentation will discuss the potential of DMX-101 as a Phase 2-ready non-addictive opioid for chronic pain
September 19, 2023
August 15, 2023
Potential to treat chronic pain without risks associated with traditional opioids by exclusively targeting peripheral pain receptors
PRESENTATIONS AND PUBLICATIONS
October 17, 2023
BIO Investor Forum 2023 - Presentation by Nikhilesh Singh, PhD
September 6, 2023